Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 214 participants.

Also called NCT04346004

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 214 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04346004
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04346004. Randomized; quadruple masking; primary purpose prevention. Start 2020-04-27 (actual); primary completion 2023-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation
Condition
Aortic Stenosis (Treated With TAVI)
Intervention (Drug)
Normal saline
Intervention (Drug)
Iron isomaltoside
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct04346004
Content hash
02d4478e1d52f9bfbcf511e61ef83cddd44ef37251324b6040516c569d37fc7c